Company profile
MyCardium AI
Mycardium Ai Limited is a UK company with status active founded in 2022.
Updated 06 Jun 2026 16:52
Financial period: 1 May 2024 to 30 Apr 2025
Reference milestones and recent Companies House filing stream events.
Next accounts due date
Next confirmation statement due date
SH08 | Transaction MzUxMDIyNDA4OGFkaXF6a2N4 | Paper/PDF filed
Published 27 Mar 2026 01:56
SH10 | Transaction MzUxMDIyNDA4OWFkaXF6a2N4 | Paper/PDF filed
Published 25 Mar 2026 00:04
Last confirmation statement made up date
Last accounts made up date
SH01 | Transaction MzQ0MjUzNzg1OGFkaXF6a2N4
Published 12 Nov 2024 04:50
SH01 | Transaction MzQ0MjEwNDgwM2FkaXF6a2N4
Published 05 Nov 2024 11:33
CS01 | Transaction MzQ0MTgyMjQzMWFkaXF6a2N4
Published 02 Nov 2024 02:57
MR01 | Transaction MzQ0MDg2ODI3MmFkaXF6a2N4
Published 30 Oct 2024 12:31
SH01 | Transaction MzQzOTQwMTE1OWFkaXF6a2N4
Published 14 Oct 2024 11:32
SH01 | Transaction MzQzOTI0NDcyNWFkaXF6a2N4
Published 12 Oct 2024 11:32
SH01 | Transaction MzQzOTIxNDgxNGFkaXF6a2N4
Published 11 Oct 2024 11:33
SH01 | Transaction MzQzODk3MjAyNmFkaXF6a2N4
Published 09 Oct 2024 11:32
SH01 | Transaction MzQzODgwNzIyOWFkaXF6a2N4
Published 08 Oct 2024 11:33
SH01 | Transaction MzQzODY0NjMzMmFkaXF6a2N4
Published 07 Oct 2024 11:31
SH01 | Transaction MzQzODUyMjI3NmFkaXF6a2N4
Published 06 Oct 2024 11:33
SH01 | Transaction MzQzODUwMzU0MGFkaXF6a2N4
Published 05 Oct 2024 11:33
SH01 | Transaction MzQzODQ3MDQzMmFkaXF6a2N4
Published 04 Oct 2024 11:32
CH01 | Transaction MzQzMjQ3Nzc0OWFkaXF6a2N4
Published 16 Aug 2024 09:56
RESOLUTIONS | Transaction QUQ5MDNLWE5hZGlxemtjeA | Paper/PDF filed
Published 13 Aug 2024 07:52
SH06 | Transaction MzQzMTU5OTg1OGFkaXF6a2N4 | Paper/PDF filed
Published 08 Aug 2024 13:13
SH03 | Transaction MzQzMTU5OTg1NWFkaXF6a2N4 | Paper/PDF filed
Published 08 Aug 2024 12:36
Company registered at Companies House
6 Dec 2024 to 6 Dec 2026
**Heart disease treatment** is undergoing a revolution. First-in-class drug and gene therapies, precisely targeting the underlying heart muscle genetic or pathological causes have now been developed, trialled, and approved with many more in the multi-billion dollar pipeline. Cardiac imaging underpins clinical trails, and is essential for clinical care. Pr...
6 Dec 2024 to 6 Dec 2026
**Heart disease treatment** is undergoing a revolution. First-in-class drug and gene therapies, precisely targeting the underlying heart muscle genetic or pathological causes have now been developed, trialled, and approved with many more in the multi-billion dollar pipeline. Cardiac imaging underpins clinical trails, and is essential for clinical care. Pr...
1 Aug 2023 to 31 Jul 2025
**Cardiomyopathy** is a disease that affects the heart muscle and can cause heart failure and sudden death. The most common genetic type of this disease is called hypertrophic cardiomyopathy, which thickens the heart. In the last few years, the first of new drugs and gene therapies have been developed to treat this disease more precisely. These are real b...
